Literature DB >> 17482347

Modulation of cyclin D1 expression in human tumoral parathyroid cells: effects of growth factors and calcium sensing receptor activation.

S Corbetta1, C Eller-Vainicher, L Vicentini, A Lania, G Mantovani, P Beck-Peccoz, A Spada.   

Abstract

The study investigated cyclin D1 regulation by growth factors and calcium sensing receptor (CaSR) in human tumoral parathyroid cells. Basic fibroblast and epidermal growth factors increased cyclin D1 and phosphorylated extracellular signal-regulated kinases (pERK1/2) levels that were both efficiently inhibited by CaSR agonists. By contrast, in growth factors-free medium cyclin D1 levels were either unaffected or stimulated by CaSR activation independently from ERK1/2 pathway. Transforming growth factor beta (TGFbeta) reduced cyclin D1 levels in the majority of tumors, this effect being not influenced by CaSR activation and menin expression levels. In conclusion, in parathyroid tumors cyclin D1 expression was modulated by growth factors and CaSR activation. These data further support the oncogenic role of cyclin D1, which resulted to be target for stimulation by bFGF and EGF and inhibition by CaSR and TGFbeta signalling in the parathyroid.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482347     DOI: 10.1016/j.canlet.2007.03.014

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

1.  Expression of parathyroid-specific genes in vascular endothelial progenitors of normal and tumoral parathyroid glands.

Authors:  Sabrina Corbetta; Marzia Belicchi; Federica Pisati; Mirella Meregalli; Cristina Eller-Vainicher; Leonardo Vicentini; Paolo Beck-Peccoz; Anna Spada; Yvan Torrente
Journal:  Am J Pathol       Date:  2009-07-30       Impact factor: 4.307

Review 2.  Calcium-sensing receptor in colorectal inflammation and cancer: Current insights and future perspectives.

Authors:  Luca Iamartino; Taha Elajnaf; Enikö Kallay; Martin Schepelmann
Journal:  World J Gastroenterol       Date:  2018-09-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.